Expected acquisitions of biopharma companies by type of asset 2021
For 2021, 71 percent of surveyed investment professionals expect that biopharmaceutical companies will target early stage, highly innovative assets. This statistic illustrates the percentage of expected acquisitions by biopharmaceutical companies in 2021, by type of asset.